Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Trametinib DMSO (API) is a dimethyl sulfoxide solution of the MEK1/2 inhibitor Trametinib, utilized in pharmaceutical R&D and clinical trials. The active moiety follows the molecular formula C26H20N4O3 with CAS 968077-70-5. Production involves precise synthesis followed by solubilization in DMSO to ensure high purity for research applications.
Application
- Oncology Research: Investigating MAPK pathway inhibition in melanoma and NSCLC models.
- Drug Development: Serving as a reference standard for potency assays and formulation studies.
- In Vitro Screening: Utilized in high-throughput screening to evaluate kinase inhibitor efficacy.
Precautions
This substance is strictly for research use only, not approved for human therapy. Store at -20°C under inert atmosphere to prevent degradation. Handle with appropriate PPE due to potential toxicity and skin absorption risks associated with DMSO carriers.